期刊文献+
共找到62篇文章
< 1 2 4 >
每页显示 20 50 100
Expression and Significance of Coxsackie and Adenovirus Receptor in Renal-Cell Carcinoma
1
作者 Linlin Zhang Dalin He +4 位作者 Xiang Li Lei Li Yong Luo Linhua Yu Hsieh JT 《Chinese Journal of Clinical Oncology》 CSCD 2005年第5期787-790,共4页
OBJECTIVE To investigate the expression of Coxsackie and Adenovirus receptor (CAR) in renal-cell carcinoma and the relationship of the CAR to the biological behavior of the carcinomas. METHODS The immunohistochemica... OBJECTIVE To investigate the expression of Coxsackie and Adenovirus receptor (CAR) in renal-cell carcinoma and the relationship of the CAR to the biological behavior of the carcinomas. METHODS The immunohistochemical SP method was used to detect the expression of Coxsackie and Adenovirus receptor in 48 cases of renal- cell carcinoma and in 12 cases of normal renal tissue 2 cm away from the tumor tissue. RESULTS The positive rates of CAR were 100% in 12 cases of para-tumor normal renal tissue and 35.4% in 48 cases of renal-cell carcinoma respectively. The difference of CAR expression between them was significant (P〈0.05). The grades of the tumor were as follows: 22 in Grade Ⅰ, 17 in Grade Ⅱ and 9 in Grade Ⅲ with the CAR positive rate being 54.5%, 23.5% and 11.1%, respectively. There was a negative correlation between CAR expression and tumor grading (P〈0.05). In addition, the number of the cases in stages I to IV were 19, 13, 11 and 5 respectively, with the respective positive rates being 57.9%, 30.8%, 18.2% and 0.0%, i.e. there also was a negative relationship between CAR expression and the stage (P〈0.05). CONCLUSION CAR expression is down-regulated in renal-cell carcinoma compared with normal tissue. The level of CAR may be a sensitive predictor of differentiation, invasion and metastasis. Loss of CAR expression correlates with the invasive phenotype in our analysis of renal-cell carcinoma. 展开更多
关键词 renal-cell carcinoma coxsackie and adenovirus receptor immunohistochemistry.
下载PDF
ROLE OF COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR (CAR)IN CARDIOTOXICITY INFECTED BY COXSACKIEVIRUS B3
2
作者 赵武 周爱卿 +2 位作者 傅立军 梁瑛 唐宁 《Journal of Shanghai Second Medical University(Foreign Language Edition)》 2005年第2期128-131,共4页
Objective To explore the role of coxsackievirus and adenovirus receptor(CAR) in cardiotoxicity infected by coxsackieviras B3. Methods A toxic cellular model was established in vitro by adding myocarditic coxsackievi... Objective To explore the role of coxsackievirus and adenovirus receptor(CAR) in cardiotoxicity infected by coxsackieviras B3. Methods A toxic cellular model was established in vitro by adding myocarditic coxsackievirus B3 (CVB3m) into the culture of neonatal mouse cardiomyocytes. 48 h later, the cardiomyocytes were divided into control, CVB3m, and CAR antibody + CVB3m groups. CVB3m-mediated myocytopathic effect of above three groups was observed after further culturing for 48h. At the same time, the cardiomyocytes' viability of above three groups was assessed by MTT assay. Results The degree of cytopathic effect(CPE) of CAR antibody + CVB3m group was significantly lower than CVB3m group ( P 〈 0. 01 ) and there was a significant increase in cell viability in CAR antibody + CVB3m group compared with CVB3m group( P 〈 0. 01 ). No significant difference was found between CAR antibody + CVB3m group and control group. Conclusion CAR antibody possesses a protective effect on CVB3m infected cardiomyoctyes, which indicates that CAR may play an important role in mediating cardiotoxicity infected by CVB3m. 展开更多
关键词 coxsackievirus and adenovirus receptor(car) coxsackievirus B3 CVB3 cardiomyocytes
下载PDF
Expression of Coxsackievirus and Adenovirus Receptor in Human Lung Cancer: Possible Clinical Significance 被引量:1
3
作者 Lei-na SUN An-kang GU +4 位作者 Zhao-li CHEN Zhong-li ZHAN Qian WANG Jun-wen LI Bao-cun SUN 《Clinical oncology and cancer researeh》 CAS CSCD 2010年第1期48-54,共7页
OBJECTIVE To explore the relationship between CAR and the development of human lung cancer, as well as to provide the basis for the clinical treatment of lung cancer using an adenovirus vector-based gene therapy. METH... OBJECTIVE To explore the relationship between CAR and the development of human lung cancer, as well as to provide the basis for the clinical treatment of lung cancer using an adenovirus vector-based gene therapy. METHODS CAR expression was assessed immunohisto- chemically in tumoral, paraneoplastic and normal samples from 112 lung cancer patients. At the same time, the mRNA and protein expression of CAR in 32 cases were determined by RT-PCR and Western blot. The relationship between CAR expression and clinicopathologic parameters was statistically analyzed. RESULTS There was no expression of CAR in normal lung tissue but a little in paraneoplastic tissue. The positive rate was 43% in squamous cell carcinoma, and 70% in adenocarcinoma. Both were much significantly higher than that in paraneoplastic tissue. The CAR expression level in adenocarcinoma was higher than that in squamous cell cancer, mRNA expression by RT-PCR and protein expression by Western blot were consistent with immunohistochemistry results. CONCLUSION CAR is overexpressed in human lung cancer, especially in adenocarcinoma. This data offer the reliable basis for adenovirus-mediated gene therapy of lung cancer; more important, CAR may take part in the formation or development of lung cancer; this may be exploitable for the development of antibody-directed therapy in human lung cancer. 展开更多
关键词 coxsackie virus and adenovirus receptor protein (car lung cancer IMMUNOHISTOCHEMISTRY RT-PCR Western blot gene therapy.
下载PDF
Inhibitory Effect of Coxsackie Adenovirus Receptor on Invasion and Metastasis Phenotype of Ovarian Cancer Cell Line SKOV3
4
作者 王蓓蓓 陈刚 +3 位作者 李辅军 周剑锋 卢运萍 马丁 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2005年第1期85-87,93,共4页
Full-length coxsackie adenovirus receptor (CAR) eukaryotic expression plasmid was transfected into an ovarian cell line, SKOV3, and its effect on the change of malignant metastasis phenotype was explored. CAR mRNA and... Full-length coxsackie adenovirus receptor (CAR) eukaryotic expression plasmid was transfected into an ovarian cell line, SKOV3, and its effect on the change of malignant metastasis phenotype was explored. CAR mRNA and protein expression levels among 4 ovarian cancer cell lines (A2780, SKOV3, SW626, CAOV3) and the positive control 293 (a transformed human embryo kidney cell line) was detected by using semi-quantitative RT-RCR and Western blot and compared. CAR-negative SKOV3 was transfected with the eukaryotic expression plasmid containing a full-length CAR cDNA and mock-vector respectively. The positive clones were screened by G418. The biological behavior changes of positive transfected cells were gauged by colony formation in soft agar assay and cell adhesion assay. Among the cell lines, there were obviously different CAR expression levels. CAR could not be detected in SKOV3. In transfected cell group, CAR expression was enhanced obviously as compared with non-transfected or mock-transfected groups. Cell adhesion in the transfected group was promoted. The number of colony formation was reduced significantly in transfected groups (25.32±8.91) as compared with that in non-transfected group (88.75±13.98) and mock-transfected group (82.53±19.37). Among the 4 ovarian cancer cell lines, CAR expression level was variable. Exogenous CAR expression had a potential role in inhibiting the malignant metastasis phenotype of ovary cancer cells. 展开更多
关键词 coxsackie and adenovirus receptor INVASION METASTASIS ovarian cancer
下载PDF
Expression of coxsackie and adenovirus receptor in small cell lung cancer
5
作者 Yongyi Bao Yong Wang +4 位作者 Lingdi Ma Naifu Guan Yuqing Cheng Shizhong Wang Xiaolong Fan 《The Chinese-German Journal of Clinical Oncology》 CAS 2009年第9期504-505,共2页
Objective: We explored the expression of coxsackie and adenovirus receptor (CAR) in small cell lung cancer (SCLC) tissue. Methods: CAR expression in 31 SCLC was assessed in formaldehyde-fixed, paraffin-embedded tissue... Objective: We explored the expression of coxsackie and adenovirus receptor (CAR) in small cell lung cancer (SCLC) tissue. Methods: CAR expression in 31 SCLC was assessed in formaldehyde-fixed, paraffin-embedded tissue according to the EnVision immunohistochemistry procedure, while 3 samples of surgical specimens of non-malignant lung disease were taken as the negative control. Results: We observed that the expression of CAR was detectable positive in all the 31 cases from the small cell lung cancer tissue, in contrasting that non-malignant lung tissue control. Conclusion: The high expression of CAR appeared in SCLC tissue indicates that it play an important role in of adenovirus vector-based gene therapy in SCLC. 展开更多
关键词 coxsackie and adenovirus receptor IMMUNOHISTOCHEMISTRY small cell lung cancer gene therapy
下载PDF
Expression of Coxsackie and Adenovirurus Receptor and its Significance in Human Lung Cancer
6
作者 Qian Wang Zhongli Zhan +1 位作者 Yi Pan Junwen Li 《Chinese Journal of Clinical Oncology》 CSCD 2007年第4期273-276,共4页
OBJECTIVE To study the relationship between the coxsackie and adenovirus receptor (CAR) and the development of human lung cancer. To optimize adenovirus vector-based gene therapy.METHODS The expression of CAR in 112... OBJECTIVE To study the relationship between the coxsackie and adenovirus receptor (CAR) and the development of human lung cancer. To optimize adenovirus vector-based gene therapy.METHODS The expression of CAR in 112 cases of lung cancer was examined using immunohistochemistry. At the same time, the relationship between CAR expression and clinicopathologic characteristics was analyzed,RESULTS :lhere is a little expression of CAR in normal lung tissue. Compared with paraneoplastic epithelial tissue of the lung, the expression of CAR is generally up-regulated in tumor tissues showing a significant dif- ference (P〈0.01). The positive rate of CAR expression in squamous cell carcinoma was 43.1%, and in adenocarcinoma 70.2%, with the difference between the two rates being statistically significant (P〈0.01). Compared to the paraneoplastic tissues, the difference in CAR positive expression was 35.4% for squamous cell carcinoma and 38.3% for adenocarcinoma. But the difference in different stages of squamous cell carcinoma had no statistical significance (P〉0.05). However, the expression of CAR was at a high level in the bronchioalveolar carcinomas as 80.4% were CAR positive. This research showed that there was a specially high expression of CAR in adenocarcinomas.CONCLUSION CAR is expressed in human lungs at a low level and up-regulated in the tumor tissues, suggesting that there is a relationship between adenocarcinoma and CAR. This research provides a basis for planning a regimen of gene therapy using an adenovirus vector, 展开更多
关键词 coxsackie and adenovirus receptor/car lung cancer gene therapy.
下载PDF
Down-regulation of Coxsakie and Adenovirus Receptor during Embryo Implantation
7
作者 李豫峰 赵焕 +5 位作者 王蓓蓓 崔丹丹 袁素珍 贺晓 郭娜 陈宁宁 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2012年第1期103-106,共4页
In this study,real-time PCR and immunohistochemistry were used to detect coxsakie and adenovirus receptor (CAR) expression.Both localization and quantity were evaluated in the uteri ob-tained at days post coitus (dpc)... In this study,real-time PCR and immunohistochemistry were used to detect coxsakie and adenovirus receptor (CAR) expression.Both localization and quantity were evaluated in the uteri ob-tained at days post coitus (dpc) 2.5,4.5,6.5,8.5.Outcome of PCR was assessed by 2-ΔΔCt method.Im-age Pro-Plus 6.0 software was used for quantifying mean density of CAR expression in immunohisto-chemical sections.We found relatively weak CAR expression in the mouse uteri during implantation window.PCR and immunohistochemistry revealed highest CAR expression was detected on dpc 2.5 followed by down-regulation of CAR at dpc 4.5 and 6.5 (with significant difference).At dpc 8.5,CAR expression was increased slightly again.It is concluded that during implantation,the expression of CAR mRNA and protein is declined,resulting in the impairment of tight junction between cavity epithelium cells.After implantation window closure,CAR appears again to maintain epithelium stability.CAR might play an important role during embryo implantation procedure. 展开更多
关键词 coxsackie and adenovirus receptor embryo implantation ENDOMETRIUM
下载PDF
肿瘤细胞CAR表达水平与5型腺病毒转导效率的关系 被引量:2
8
作者 王海娟 李云峰 +5 位作者 钱海利 张雪燕 付明 梁萧 詹启敏 林晨 《中国肿瘤生物治疗杂志》 CAS CSCD 2006年第6期429-434,共6页
目的:通过体外、体内实验探讨肿瘤细胞柯萨奇腺病毒受体(coxsackie adenovirus receptor,CAR)表达水平与腺病毒转导效率的关系,为腺病毒相关的生物制剂在临床个体化应用提供实验依据。方法:将载有绿色荧光蛋白的Ad5型腺病毒(Ad.... 目的:通过体外、体内实验探讨肿瘤细胞柯萨奇腺病毒受体(coxsackie adenovirus receptor,CAR)表达水平与腺病毒转导效率的关系,为腺病毒相关的生物制剂在临床个体化应用提供实验依据。方法:将载有绿色荧光蛋白的Ad5型腺病毒(Ad.GFP)以100MOI、200MOI分别感染人食管癌细胞系KYSE510、KYSE150、EC9706、人宫颈癌细胞系HeLa、人卵巢癌细胞系SKOV3、人肝癌细胞系HepG2和人肺癌细胞系A549,感染后48h通过流式细胞术检测Ad—GFP对不同细胞系的转导效率。采用Western blotting方法检测这些细胞中CAR的表达水平。将HeLa、A549、SKOV3、EC9706细胞分别接种于裸鼠腋下,接种细胞数分别为3×10^6、3×10^6、3×10^6、2×10^6,建立裸鼠移植瘤模型。待肿瘤长径达5~7mm时,在裸鼠移植瘤内注射Ad—GFP,每次1×10^9PFU,间隔48h注射第2次。第2次注射后48h处死裸鼠,剖取瘤组织,荧光显微镜观察冰冻切片中GFP的表达情况以判定腺病毒在瘤体内的转导效率,同时用免疫组化法检测瘤组织内的CAR表达水平。结果:200MOIAd—GFP感染A549、HeLa、HepG2、KYSE150细胞48h后分别有92.67%、89.31%、84.98%、74.59%的细胞表达GFP;而SKOV3、KYSE510、EC9706细胞中腺病毒的转导效率明显降低,GFP阳性率分别为30.06%、27.40%、18.93%;各种细胞的CAR蛋白表达水平与腺病毒的转导效率呈正相关。注射Ad—GFP的裸鼠移植瘤组织中可见HeLa、A549瘤组织内有明显的点状绿色荧光,而SKOV3、EC9706瘤组织内表达GFP的细胞数明显少于前两种瘤组织;HeLa、A549裸鼠移植瘤组织内大多数瘤细胞高表达CAR(卅),SKOV3、EC9706移植瘤组织内CAR表达水平较低(+或-),表明瘤体内CAR表达水平与Ad.GFP的转导效率也呈正相关。结论:体内外实验均显示肿瘤细胞的CAR表达水平与5型腺病毒转导效率密切相关。肿瘤患者治疗前检测组织中CAR表达水平有助于规范腺病毒载体的基因治疗药物的个体化使用。 展开更多
关键词 肿瘤 腺病毒 柯萨奇腺病毒受体 基因治疗
下载PDF
CAR抑制卵巢癌细胞株SKOV3侵袭转移表型的研究 被引量:3
9
作者 王蓓蓓 陈刚 +3 位作者 李辅军 周剑锋 卢运萍 马丁 《癌症》 SCIE CAS CSCD 北大核心 2005年第9期1054-1058,共5页
背景与目的:柯萨奇-腺病毒受体(coxsackieandadenovirusreceptor,CAR)最早作为2,5型腺病毒的受体而被人们发现和认识,近年的研究发现它还是粘附分子家族的一员,并参与肿瘤恶性表型改变。本研究通过转染真核表达载体,探讨其对卵巢癌细胞... 背景与目的:柯萨奇-腺病毒受体(coxsackieandadenovirusreceptor,CAR)最早作为2,5型腺病毒的受体而被人们发现和认识,近年的研究发现它还是粘附分子家族的一员,并参与肿瘤恶性表型改变。本研究通过转染真核表达载体,探讨其对卵巢癌细胞株SKOV3侵袭转移表型的影响。方法:利用Westernblot和RT-PCR检测4株卵巢癌细胞CAR的表达;脂质体介导转染含有全长CAR基因的真核表达质粒至SKOV3细胞,经G418筛选出稳定表达的阳性细胞克隆;体外粘附实验及软琼脂克隆形成实验验证CAR对SKOV3侵袭转移表型的影响。结果:4株卵巢癌细胞中,CAR表达水平不同程度下调,其中SKOV3细胞CAR表达缺失。转染后,SKOV3细胞CARmRNA和蛋白质水平表达均明显增高;细胞间粘附力明显增强;软琼脂克隆实验显示转染细胞每孔克隆形成数(25.3±8.9)明显低于未转染组(88.8±14.0)和转染空质粒组(82.5±19.4)。结论:外源性CAR基因的导入可以增强卵巢癌细胞SKOV3间的粘附性,从而抑制肿瘤细胞的侵袭转移表型。 展开更多
关键词 卵巢癌/病理学 SKOV3细胞株 柯萨奇-腺病毒受体 侵袭 转移
下载PDF
非小细胞肺癌中CAR和CD46的表达及临床意义 被引量:1
10
作者 马玲娣 刘乾 +5 位作者 王勇 王仕忠 鲍永仪 关乃富 倪诚 樊小龙 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第11期1268-1271,共4页
目的研究柯萨奇-腺病毒受体(Coxsackie and adenovirus receptor,CAR)及B组腺病毒受体CD46分子在人非小细胞肺癌(Non-small cell lung carcinoma,NSCLC)组织中的表达水平及临床意义。方法免疫组织化学方法检测144例NSCLC组织中CAR、CD4... 目的研究柯萨奇-腺病毒受体(Coxsackie and adenovirus receptor,CAR)及B组腺病毒受体CD46分子在人非小细胞肺癌(Non-small cell lung carcinoma,NSCLC)组织中的表达水平及临床意义。方法免疫组织化学方法检测144例NSCLC组织中CAR、CD46的表达,对两者的表达水平与腺病毒的转染效率以及肺癌发生、发展之间的关系进行分析。结果 144例NSCLC组织中,CAR在肺鳞癌和肺腺癌中CAR的阳性表达率分别为77.5%(31/40)和36.8%(14/38);CD46则分别为58.3%(14/24)和88.1%(37/42);不同病理类型NSCLC组织中,CAR和CD46的表达模式明显不同(P<0.05)。此外,CAR表达与NSCLC临床TNM分期密切相关。30例TNMⅠ期患者中,13例CAR表达阳性(43.3%),48例Ⅱ~Ⅲ期患者中,32例CAR表达阳性(66.7%),Ⅱ~Ⅲ期患者的CAR阳性表达率明显高于Ⅰ期患者(P<0.05)。结论 CAR及CD46在NSCLC中的表达水平明显不同,鳞癌普遍高表达CAR,腺癌则有CD46的高表达,提示依赖不同受体的腺病毒对NSCLC的基因转移效率也有所不同;CAR表达水平可能是判断NSCLC预后的有用指标。 展开更多
关键词 非小细胞肺癌 柯萨奇-腺病毒受体 CD46 基因治疗
下载PDF
CAR在柯萨奇B3病毒感染心肌细胞中作用 被引量:2
11
作者 赵武 周爱卿 +2 位作者 傅立军 梁瑛 唐宁 《临床儿科杂志》 CAS CSCD 北大核心 2004年第11期748-750,753,共4页
目的探讨柯萨奇病毒和腺病毒受体(coxsackievirusandadenovirusreceptor,CAR)在嗜心性柯萨奇B3病毒(myocarditiccoxsaekievirusB3,CVB3m)感染心肌细胞中的作用。方法采用体外培养新生小鼠心肌细胞方法,建立CVB3m感染心肌细胞模型,将培养... 目的探讨柯萨奇病毒和腺病毒受体(coxsackievirusandadenovirusreceptor,CAR)在嗜心性柯萨奇B3病毒(myocarditiccoxsaekievirusB3,CVB3m)感染心肌细胞中的作用。方法采用体外培养新生小鼠心肌细胞方法,建立CVB3m感染心肌细胞模型,将培养48h的心肌细胞分为对照组、CVB3m组和CAR抗体+CVB3m组,并作相应处理,继续培养48h后,分别观察各组心肌细胞病变效应(cytopathiceffect,CPE),并用四唑盐(MTT)比色法测定各组心肌细胞存活力。结果CAR抗体+CVB3m组心肌细胞CPE明显减轻,存活力显著增强,与CVB3m组比较差异显著(P<0.01),与对照组比较差异无显著性(P>0.05)。结论CAR抗体对CVB3m感染心肌细胞具有保护作用,提示CAR在CVB3m感染心肌细胞中可能发挥重要的介导作用。 展开更多
关键词 柯萨奇病毒和腺病毒受体 柯萨奇B3病毒 心肌细胞 小鼠
下载PDF
CAR在具有细支气管肺泡癌特征肺癌中的表达及意义 被引量:2
12
作者 郭燕 张军 +1 位作者 李海欣 战忠利 《中国肿瘤临床》 CAS CSCD 北大核心 2014年第5期296-299,共4页
目的:探讨柯萨奇病毒-腺病毒受体(CAR)在肺腺癌部分亚型中的表达及其与临床病理和患者预后的关系。方法:采用EnVision免疫组化二步法检测CAR在137例具有细支气管肺泡癌特征的肺癌(PWBF)组织中的表达,分析其与临床因素的相关性;并收集患... 目的:探讨柯萨奇病毒-腺病毒受体(CAR)在肺腺癌部分亚型中的表达及其与临床病理和患者预后的关系。方法:采用EnVision免疫组化二步法检测CAR在137例具有细支气管肺泡癌特征的肺癌(PWBF)组织中的表达,分析其与临床因素的相关性;并收集患者的生存资料,采用Kaplan-Meier曲线描述生存率,行Log-rank检验。结果:CAR在PWBF、其他类型肺癌及正常组织中的阳性率分别为71.5%、50.0%、13.3%,其差异具有统计学意义;CAR蛋白的表达与病理分型和组织学分级相关,与性别、年龄、临床分期等无关。CAR阳性表达患者的生存时间较阴性者长,但无统计学差异。结论:CAR的表达与肺癌的发生发展相关,并同肺腺癌部分亚型(PWBF)的关系密切。CAR在PWBF中的较高表达为以腺病毒(Ad)载体的基因治疗开辟了更为广阔的空间;同时CAR的高度可调节性也为肺癌其他类型的基因治疗提供了可靠的依据和美好的前景。 展开更多
关键词 柯萨奇病毒-腺病毒受体 肺癌 细支气管肺泡
下载PDF
曲古菌素A通过抑制MAPK/ERK通路上调食管癌EC1细胞CAR的表达 被引量:2
13
作者 马俊芬 刘康栋 +4 位作者 刘霞 杨洪艳 黄幼田 赵明耀 董子明 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2010年第2期139-143,共5页
目的:观察曲古菌素A(trichostatin A,TSA)对人食管癌细胞EC1膜表面柯萨奇病毒-腺病毒受体(Coxsachievirus and adenovirus receptor,CAR)表达水平的影响,探讨MAPK/ERK信号通路在TSA上调CAR表达中的作用。方法:0.3、0.5、1.0μmol/L的TS... 目的:观察曲古菌素A(trichostatin A,TSA)对人食管癌细胞EC1膜表面柯萨奇病毒-腺病毒受体(Coxsachievirus and adenovirus receptor,CAR)表达水平的影响,探讨MAPK/ERK信号通路在TSA上调CAR表达中的作用。方法:0.3、0.5、1.0μmol/L的TSA处理EC1细胞48h,采用免疫荧光、RT-PCR、Western blotting检测CAR的表达。以1.0μmol/LTSA作用EC1细胞1、6、12、24、48h,Western blotting检测p-ERK、CAR表达水平的变化,分析CAR表达和p-ERK水平变化的相关性。结果:0.3、0.5、1.0μmol/LTSA处理EC1细胞后,CAR蛋白和mRNA水平均明显增加(P<0.05),并呈剂量依赖关系。1.0μmol/LTSA作用EC1细胞6、12、24、48h后,CAR蛋白表达较对照组均明显增加(P<0.05);p-ERK表达水平均明显下降(P<0.05),两者变化呈显著负相关(r=-0.886,P<0.01)。结论:TSA能够上调人食管癌EC1细胞膜表面CAR的表达水平,其机制可能与其抑制MAPK/ERK通路有关。 展开更多
关键词 食管癌细胞 曲古菌素A 柯萨奇病毒-腺病毒受体 细胞外信号调节激酶
下载PDF
曲古菌素A上调食管癌CAR的表达及增强溶瘤腺病毒转染效率的体外研究 被引量:1
14
作者 冯婷 刘霞 +2 位作者 黄幼田 杨红艳 董子明 《第三军医大学学报》 CAS CSCD 北大核心 2010年第22期2404-2408,共5页
目的通过观察组氨酸去乙酰化酶(histone deacetylase,HDAC)抑制剂曲古菌素(trichostatin A,TSA)对食管癌细胞株EC9706膜表面柯萨奇-腺病毒受体(Coxsackie and adenovirus receptor,CAR)表达水平的影响,观察TSA能否通过上调食管癌EC9706... 目的通过观察组氨酸去乙酰化酶(histone deacetylase,HDAC)抑制剂曲古菌素(trichostatin A,TSA)对食管癌细胞株EC9706膜表面柯萨奇-腺病毒受体(Coxsackie and adenovirus receptor,CAR)表达水平的影响,观察TSA能否通过上调食管癌EC9706CAR表达而增强其对腺病毒基因转染效率。方法采用免疫细胞组织化学、RT-PCR、Western blot检测食管癌EC9706细胞CAR的表达情况,再用上述方法检测TSA作用EC9706细胞后,CAR mRNA和CAR蛋白表达的改变;同时采用流式细胞术测定病毒转染效率,MTT实验评价腺病毒携带的胸苷激酶(Ad-TK)的体外抗瘤效应。结果 0.5μmol/LTSA处理EC9706细胞12、24、48h后,CAR mRNA和蛋白表达量[分别为(0.44±0.01)、(0.37±0.02),(0.66±0.04)、(0.58±0.01),(0.77±0.05)、(0.70±0.03)]与未加TSA处理组[(0.27±0.02)、(0.22±0.03)]相比,CAR mRNA和蛋白表达水平显著提高(P<0.05,P<0.01),呈现出时间依赖关系。流式细胞仪分析Ad-GFP转染后GFP的表达发现,未加TSA处理细胞转染效率为(1.35±0.11)%,0.5μmol/L TSA作用12、24h和48h后,细胞转染效率分别为(2.58±0.17)%、(4.96±0.14)%、(6.36±0.15)%。MTT检测Ad-TK介导的体外杀伤作用结果显示,0.5μmol/L TSA作用48h比未加TSA增强8倍。结论 TSA通过上调CAR表达量从而增强腺病毒对食管癌细胞的腺病毒基因转染效率。 展开更多
关键词 柯萨奇-腺病毒受体 曲古菌素 食管癌细胞株EC9706 腺病毒 基因转染
下载PDF
53基因及CAR受体对ONYX-015肿瘤杀伤作用的影响 被引量:1
15
作者 陈洁 达万明 +2 位作者 钱其军 苏长青 崔贞福 《临床肿瘤学杂志》 CAS 2005年第2期113-116,共4页
目的:利用肿瘤特异性增殖型腺病毒ONYX-015分别感染具有柯萨奇病毒和腺病毒联合受体(CAR)水平正常、p53正常或突变的,以及CAR水平低下、p53突变的肿瘤细胞株,研究ONYX 015对这些肿瘤细胞的特异性增殖及杀伤能力。方法:以正常的肝细胞株... 目的:利用肿瘤特异性增殖型腺病毒ONYX-015分别感染具有柯萨奇病毒和腺病毒联合受体(CAR)水平正常、p53正常或突变的,以及CAR水平低下、p53突变的肿瘤细胞株,研究ONYX 015对这些肿瘤细胞的特异性增殖及杀伤能力。方法:以正常的肝细胞株L02作为对照,用细胞病变效应(CPE)实验观察ONYX-015对细胞的选择性杀伤效应;病毒增殖实验检测野生型腺病毒(Ad5)、ONYX 015在多种肿瘤细胞中的增殖能力。结果:ONYX 015对正常的肝细胞L02无杀伤性,但能够有效地杀伤p53突变的肝癌细胞Hep3B、p53正常的肝癌细胞HepG2及肺癌细胞A549,不能杀伤p53突变的人乳腺癌细胞株MDA-MB 231。在CAR受体水平正常的癌细胞株Hep3B、HepG2和A549中,Ad5和ONYX-015均可增殖。在CAR受体水平低下、p53突变的人乳腺癌细胞株MDA-MB 231中,两种病毒均不增殖。结论:CAR受体对ONYX-015的增殖力起着至关重要的作用。在CAR受体水平正常的前提下,无论肿瘤细胞的p53基因正常与否,ONYX-015均可以有效增殖并杀伤细胞;相反,如果CAR受体水平低下,即使该种肿瘤细胞p53基因突变,ONYX-015在该细胞中的增殖力也会受到限制。ONYX-015不杀伤CAR受体及p53基因均正常的正常肝细胞。 展开更多
关键词 肿瘤特异性增殖病毒 ONYX-015 P53基因 柯萨奇病毒和腺病毒联合受体(car)
下载PDF
胰腺癌细胞CAR受体表达与5型腺病毒转导效率的关系 被引量:1
16
作者 张克君 李德春 朱东明 《医学与哲学(B)》 2007年第12期53-54,共2页
本研究通过体外、体内实验探讨了不同生物特性的胰腺癌细胞系细胞表面柯萨奇腺病毒受体(CAR)表达与Ad-GFP转导效率的关系。结果发现,不同细胞的CAR表达水平不同,细胞CAR表达水平与Ad-GFP转导效率明显呈正相关。因此,胰腺癌患者治疗前检... 本研究通过体外、体内实验探讨了不同生物特性的胰腺癌细胞系细胞表面柯萨奇腺病毒受体(CAR)表达与Ad-GFP转导效率的关系。结果发现,不同细胞的CAR表达水平不同,细胞CAR表达水平与Ad-GFP转导效率明显呈正相关。因此,胰腺癌患者治疗前检测组织CAR表达水平有助于规范腺病毒载体的基因治疗药物的个体化使用,有利于提高疗效,减少病毒的副作用。 展开更多
关键词 胰腺肿瘤 腺病毒 柯萨奇腺病毒受体 基因治疗
下载PDF
人源性exCAR蛋白在大肠杆菌中的表达纯化及鉴定
17
作者 张克斌 周小波 +4 位作者 光丽霞 周世文 何晓梅 盛哈蕾 钱桂生 《重庆医学》 CAS CSCD 北大核心 2009年第21期2691-2694,共4页
目的在大肠杆菌中表达人源性柯萨奇病毒-腺病毒受体胞外区蛋白(exCAR),纯化表达蛋白并进行Western-blot-ting鉴定。方法从Hela细胞株中扩增exCAR基因片段,连接至表达质粒pET-28a(+)构建为重组质粒pET-28a-exCAR,转化至大肠杆菌BL21株中... 目的在大肠杆菌中表达人源性柯萨奇病毒-腺病毒受体胞外区蛋白(exCAR),纯化表达蛋白并进行Western-blot-ting鉴定。方法从Hela细胞株中扩增exCAR基因片段,连接至表达质粒pET-28a(+)构建为重组质粒pET-28a-exCAR,转化至大肠杆菌BL21株中,筛选高表达株,诱导表达,利用Ni+株亲和纯化表达蛋白,SDS-PAGE后,转印PVDF膜后,进行Western-blotting鉴定。结果获得纯化的大肠杆菌表达蛋白exCAR,表达形式为包涵体,经Western-blotting鉴定为人源性exCAR蛋白。结论本研究获得了纯化的exCAR表达蛋白,为下一步的蛋白复性和腺病毒感染的阻断实验提供了基础。 展开更多
关键词 腺病毒 柯萨奇-腺病毒受体 胞外区 蛋白表达与纯化 Western-blotting
下载PDF
人源性exCAR原核表达蛋白体外阻断腺病毒感染实验研究
18
作者 张克斌 周小波 +4 位作者 光丽霞 周世文 何晓梅 盛哈蕾 钱桂生 《重庆医学》 CAS CSCD 北大核心 2009年第19期2451-2453,I0001,共4页
目的在培养乳鼠心肌细胞上检测人源性柯萨奇病毒-腺病毒受体胞外区(exCAR)大肠杆菌原核表达蛋白阻断腺病毒感染的活性。方法纯化人源性exCAR表达蛋白并通过透析复性,进一步体外实验,在腺病毒感染乳鼠心肌细胞模型上检测表达蛋白阻断腺... 目的在培养乳鼠心肌细胞上检测人源性柯萨奇病毒-腺病毒受体胞外区(exCAR)大肠杆菌原核表达蛋白阻断腺病毒感染的活性。方法纯化人源性exCAR表达蛋白并通过透析复性,进一步体外实验,在腺病毒感染乳鼠心肌细胞模型上检测表达蛋白阻断腺病毒感染效率。结果获得纯化表达蛋白exCAR,经复性后,在体外实验中检测到其阻断腺病毒感染心肌细胞效应,其终浓度为500ng/mL时,获得最高阻断效率约75%。结论本研究获得了具有生物活性的exCAR表达蛋白,为腺病毒感染防治提供了新的思路和基础。 展开更多
关键词 腺病毒 柯萨奇-腺病毒受体 胞外区 蛋白纯化与复性 阻断效应
下载PDF
膀胱癌细胞CAR的表达对E1B缺失腺病毒抗瘤活性的影响
19
作者 袁中玉 管忠震 +1 位作者 张力 徐瑞华 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2005年第5期533-536,共4页
【目的】观察不同组织类型膀胱癌细胞株表达柯萨奇病毒腺病毒受体(coxsackieandadenovirusreceptor,CAR)与E1B缺失腺病毒(H101)体外感染力及体内抗瘤活性的关系。【方法】体外通过流式细胞仪法(FCM)检测不同组织类型膀胱癌细胞株表面CA... 【目的】观察不同组织类型膀胱癌细胞株表达柯萨奇病毒腺病毒受体(coxsackieandadenovirusreceptor,CAR)与E1B缺失腺病毒(H101)体外感染力及体内抗瘤活性的关系。【方法】体外通过流式细胞仪法(FCM)检测不同组织类型膀胱癌细胞株表面CAR表达,用MTT法测定病毒对它们的抑制率,以观察CAR表达与H101感染力的关系;利用裸鼠移植瘤模型,观察H101对不同移植瘤的抗瘤活性。【结果】膀胱癌细胞上CAR的表达量与H101的感染力呈正相关(r=0.952);动物移植瘤实验结果显示,H101对CAR表达高的SCaBER移植瘤的抑制率较高,有效持续的时间也较长。【结论】膀胱癌细胞株上不同的CAR表达可直接影响H101的体内外抗瘤活性。 展开更多
关键词 膀胱癌细胞 E1B缺失腺病毒 car受体 感染力
下载PDF
重组蛋白sCAR-TMTP1增强腺病毒对骨肉瘤细胞基因转染效率的研究
20
作者 罗丹枫 龚静吉 +3 位作者 程腾 魏睿 魏军成 祝文涛 《骨科》 CAS 2016年第6期442-447,共6页
目的提高腺病毒(adenovirus,ADV)在缺乏柯萨奇腺病毒受体(coxsackie and adenovirus receptor,CAR)的骨肉瘤细胞中的转染效率。方法通过昆虫(Bac-to-Bac)杆状病毒表达系统表达含有CAR胞外段(s CAR)及TMTP1肽的重组蛋白(s CAR-TMTP1),并... 目的提高腺病毒(adenovirus,ADV)在缺乏柯萨奇腺病毒受体(coxsackie and adenovirus receptor,CAR)的骨肉瘤细胞中的转染效率。方法通过昆虫(Bac-to-Bac)杆状病毒表达系统表达含有CAR胞外段(s CAR)及TMTP1肽的重组蛋白(s CAR-TMTP1),并对其纯化、鉴定。流式细胞仪分别检测骨肉瘤细胞及人胚肾细胞293(HEK293)的CAR表达水平,ADV对其的感染效率及FITC-TMTP1的结合能力。重组蛋白s CAR-TMTP1与ADV共同孵育形成复合物,流式细胞仪研究其在缺乏CAR的骨肉瘤细胞(MG-63)中的转染效率。结果表达及纯化的s CAR-TMTP1蛋白在相对分子质量约31 000处可见特异蛋白条带,感染的sf9细胞裂解上清可与兔抗小鼠s CAR单克隆抗体发生特异性反应。MG-63可与FITCTMTP1特异结合,其CAR表达水平低,ADV转染效率低。经s CAR-TMTP1修饰后的ADV/GFP对MG-63细胞的感染效率显著高于未经修饰的含报告基因GFP的ADV(ADV/GFP)。结论重组蛋白s CAR-TMTP1可显著提升ADV对缺乏CAR的骨肉瘤细胞的转染效率。 展开更多
关键词 骨肉瘤 腺病毒 TMTP1肽 柯萨奇腺病毒受体 重组蛋白 基因治疗 肿瘤细胞
下载PDF
上一页 1 2 4 下一页 到第
使用帮助 返回顶部